Active Ingredient: Norfloxacin
If you have taken more than a double dose by mistake, contact your doctor immediately. If you forget to take Norfloxacin 400 mg Do not take a double dose to make up for a forgotten tablet, just carry on with the next one as normal.
If you stop taking Norfloxacin 400 mg It is important that you complete the course of treatment, even if you begin to feel better after a few days.
If you have any further questions on the use of this product, ask your doctor or pharmacist or nurse. Like all medicines, this medicine can cause side effects, although not everybody gets them.
Allergic reactions can, very rarely, be life-threatening. Achilles tendon.
Inflammation of the liver with jaundice yellowing of the skin or whites of the eyes commonly occurs. Stop treatment and contact your doctor if you experience signs and symptoms of liver problems such as loss of appetite, jaundice, dark urine, itching or sensitivity to pressure in the abdominal cavity.
If you develop the rare side effect of severe and persistent diarrhoea whilst you are taking your tablets or after stopping your tablets you should consult your doctor.
In rare cases seizures occur.
If fits occur, stop taking this medicine. You can also report side effects directly via the Yellow Card Scheme at.
By reporting side effects you can help provide more information on the safety of this medicine. How to store Norfloxacin 400 mg Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and the carton. The expiry date refers to the last day of that month.
Store in the original package. Keep the blister in the outer carton.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. Ciprofloxacin is being licensed for the treatment of Complicated Urinary Tract Infections and Pyelonephritis due to Escherichia coli and Inhalational Anthrax post-exposure and levofloxacin was recently licensed for the treatment of Inhalational Anthrax post-exposure.
However, the Fluoroquinolones are licensed to treat lower respiratory infections in children with cystic fibrosis in the UK.